![Matthew D. Roe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew D. Roe
Nessuna posizione attualmente
Storia della carriera di Matthew D. Roe
Precedenti posizioni note di Matthew D. Roe
Società | Posizione | Inizio | Fine |
---|---|---|---|
ABCAM PLC | Vendite & Marketing | 01/01/2014 | 01/01/2017 |
Crescendo Biologics Ltd.
![]() Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | 23/06/2011 | - |
GSK PLC | Corporate Officer/Principal | - | - |
Genzyme Pharmaceuticals, Inc.
![]() Genzyme Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules. The company is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Formazione di Matthew D. Roe
Brunel University | Undergraduate Degree |
Warwick Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
Regno Unito | 6 |
Stati Uniti | 2 |
Posizioni
Corporate Officer/Principal | 3 |
Undergraduate Degree | 1 |
Masters Business Admin | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
GSK PLC | Health Technology |
ABCAM PLC | Health Technology |
Aziende private | 2 |
---|---|
Genzyme Pharmaceuticals, Inc.
![]() Genzyme Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Genzyme Pharmaceuticals develops and manufactures chemically synthesized pharmaceutical materials and technologies for the pharmaceutical industry and focuses on lipids, peptides, carbohydrates, oligonucleotides, and custom small molecules. The company is headquartered in Cambridge, MA. | Health Technology |
Crescendo Biologics Ltd.
![]() Crescendo Biologics Ltd. Miscellaneous Commercial ServicesCommercial Services Crescendo Biologics Ltd. engages in the development of new medicines based on antibody fragment technology. Its products in pipeline in dermatology include CB001, a transformational Humabody-based topical biologic for psoriasis which combines exceptional activity against a validated target with a topical route of delivery to avoid systemic side effects. The firm?s oncology products in pipeline include Humabody Multi-Specific T-Cell Engagers, Humabody Antibody Drug Conjugates and Immune Checkpoint Inhibitors. The company was founded by Michael Anthony Romanos, David Rayll Brown and John Bradshaw on November 13, 2007 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
- Borsa valori
- Insiders
- Matthew D. Roe
- Esperienza